Mucus Relief Tablet, Extended Release
Product Images NDC 53943-233

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief (NDC 53943-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Discount Drug Mart, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

233-20-ddm.jpg (233 20 Ddm)

233-20-ddm.jpg (233 20 Ddm)
This text provides information on Mucus Relief Guaifenesin Extended-Release Tablets 600 mg. The tablets contain Guaifenesin as the active ingredient, which is an expectorant that helps loosen phlegm (mucus) and bronchial secretions. The product is intended for adults and children aged 12 and over to make coughs more productive. It includes warnings not to use for children under 12 years, and to consult a doctor in cases of persistent cough, excessive phlegm, or if symptoms persist after 7 days. The directions specify dosages for adults and older children, emphasizing not to exceed 4 tablets in 24 hours. It highlights the importance of keeping the product out of reach of children, storing it at room temperature, and checking for tamper-evident packaging. The tablets aim to relieve chest congestion by thinning and loosening mucus.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.